NFH
SGMO

NEXT Financial Holdings’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

NEXT Financial Holdings’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1K Buy
+59
New +$603 ﹤0.01% 1582

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NEXT Financial Holdings's SGMO Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q1 2019: 59 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1582 among its holdings.

187 funds tracked by Wall St. Rank hold SGMO as of Q1 2019.

  • NEXT Financial Holdings held 59 shares of SANGAMO THERAPEUTICS INC worth $1K as of Q1 2019.
  • SANGAMO THERAPEUTICS INC was a new NEXT Financial Holdings position in Q1 2019.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1582 holding.
  • 187 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.